表观遗传修饰与肿瘤

肿瘤的形成受遗传学修饰和表观遗传修饰的影响。长期以来人们一直认为基因突变参与肿瘤的形成,近年来越来越多的证据表明,表观遗传修饰在肿瘤进展中同样具有非常重要的作用。表观遗传调控可以影响基因转录活性而不涉及DNA序列的改变。本文介绍了肿瘤发生发展过程中出现的表观遗传修饰异常,以及通过干预表观遗传修饰治疗肿瘤的应用前景。     

表观遗传修饰与干细胞分化调控

干细胞具有自我更新和多种分化潜能的特性。干细胞向分化细胞的转变涉及到基因表达模式的改变,与自我更新有关的基因关闭．与细胞特化有关的基因激活。表观遗传调控机制,包括DNA甲基化、组蛋白修饰和微RNA（microRNA）介导的基因调控,在多个层面上控制发育过程中基因表达。近年研究表明,动态的表观遗传调控机制在干细胞自我更新和分化中起关键作用。     

CRISPR-dCas9在动物基因转录调控和表观遗传修饰中的研究与应用

全基因组范围内的靶向基因调控是了解基因功能、操纵细胞行为以及开展生物医学研究的关键.与传统调控基因表达的方法相比,成簇的有规则间隔的短回文重复(CRISPR)-dCas9系统高度的灵活性和可编程性以及调控多个内源性基因的能力,为调控动物基因组提供了强有力和精确的靶向方法.具有DNA结合活性的核酸酶缺陷型dCas9蛋白与...     

哺乳动物胚胎发生发育与表观遗传修饰

哺乳动物受精过程中染色体构象发生剧烈的变化.来自精子高度凝缩的染色质在卵母细胞胞质环境中解凝缩,与雌性染色质融合,发生基因组重编程共同构建合子基因组,激活胚胎基因组转录,获得发育的全能性,并进一步发育成完整的胚胎.表观遗传调节机制在这一过程中起重要作用,其中主要包括DNA甲基化、组蛋白甲基化、组蛋白乙酰化及组蛋白替代,这些修饰形式改变了染色体的空间构象以及与转录调节因子的结合模式,调控染色体的活性,进而调节胚胎的发生发育.     

宿主遗传背景与肠道微生物互作研究进展

“微生物”这一名词指非常小的生物,如古菌、细菌、原生生物、真菌和病毒,肠道“微生物组”表示的是肠道微生物集合体。它们实际上共享宿主的身体空间,但作为宿主健康和疾病的决定因素却几乎被忽视。作为信息的集合,微生物组包括微生物的基因组数据、结构元件、代谢物和环境条件。最近对肠道微生物组的研究表明,微生物群落在维持宿主稳态和调节宿主表型上发挥着重要作用。随着包括二代测序(next-generation sequencing, NGS)在内的新技术的出现以及微生物群落序列谱等深入测定技术出现,人们对肠道微生物组与宿主遗传背景之间的关系有了许多见解。本文通过肠道微生物组学的概述,基于全基因组关联分析技术建立肠道微生物组学与宿主遗传之间联系,并对宿主遗传学与肠道微生物组的关系及未来发展前景进行探讨。     

植物表观遗传修饰与病原菌胁迫应答研究进展

真核生物基因表达受到染色质结构的调控,组蛋白与DNA的共价修饰构成表观遗传标签,并在植物胁迫应答如防御病原菌侵染过程中起重要作用.病原菌侵染可引起基因组整体DNA甲基化模式变化及胁迫应答基因的位点特异性去甲基化,导致植物抗性基因表达上调或下调,并进一步调控植物对病原菌的胁迫应答;组蛋白去乙酰化酶HDAC通过茉莉酸途径增强植物对病原菌的胁迫应答;此外,染色质重塑复合物Swr1复合体通过识别DNA基元和组蛋白乙酰化修饰状态靶向基因启动子,负调控SA敏感基因.该文从DNA甲基化、组蛋白乙酰化、甲基化修饰,染色质重塑等方面着重阐述植物与病原菌互作过程中发生的主要事件的分子基础及其研究进展.     

表观遗传DNA甲基化与糖尿病研究进展

糖尿病是受遗传和环境共同调控的一种代谢性疾病,发病率高且难以治愈。表观遗传DNA甲基化与糖尿病进程密切相关,是联通环境因素与基因因素的桥梁,DNA甲基化通过其对基因表达的调节作用影响疾病的发生与发展。肠道微生物菌群是糖尿病研究的新兴热点方向,能够提供甲基供体等有利于甲基化的便利条件。与肠道微生物菌群及其他相关代谢通路有关的DNA甲基化与糖尿病存在着密切的关系,其为解释糖尿病的致病机理及寻找有效干预糖尿病的手段提供了新的研究线索和思路。     

表观遗传修饰介导的植物胁迫记忆

植物因其固着生长的方式, 已经进化出各类特殊的机制来适应多变的外界环境。为提高自身的存活率, 植物进化出一类胁迫记忆机制, 以适应环境和保护自己。表观遗传修饰不仅能调控植物的正常生长发育, 而且参与植物对各种非生物或生物胁迫的响应。近年的研究表明, 表观遗传修饰在植物胁迫记忆调控中也发挥重要作用。例如, DNA甲基化、组蛋白甲基化及乙酰化等表观遗传修饰参与并维持特定的胁迫记忆。该文主要对表观遗传修饰介导的植物胁迫记忆最新进展进行综述, 并展望未来的重点和热点研究方向。     

肠道微生物基因组学与代谢组学分析联合应用的研究进展

随着肠道微生物对人类健康与疾病的作用日渐受到关注,肠道微生物的代谢作用已成为近年研究的热门领域之一.已有研究表明,将肠道微生物组学与代谢组学应用于宿主生理、疾病病理、药物药理等方面的研究具有重要价值.本文就肠道微生物基因组学和代谢组学分析联合应用的研究进展进行综述.     

表观遗传修饰在调控寿命中的作用

表观遗传修饰是生命现象中普遍存在的一类基因调控方式,主要包括DNA甲基化、组蛋白乙酰化和组蛋白甲基化等,通常协同调控基因表达。端粒是位于真核生物染色体末端的保护性结构,在端粒以及亚端粒区域中也存在丰富的表观遗传修饰。随着研究深入,发现表观遗传修饰在调控寿命过程中扮演着重要角色,而揭示衰老的有关机制有助于我们找到延长寿命的方法,具有重大的生物学意义和临床应用前景。     

表观遗传调控植物叶片衰老的研究进展

植物叶片衰老是一个非常重要的发育过程,涉及大分子的有序分解从而将营养物质从叶片转移到其他器官,对植物的生存和适应至关重要。叶片衰老主要受植物的发育调控,但同时也受内部和外部环境因素的影响,涉及高度复杂的基因调控网络和多层级的调控。近年来的研究表明表观遗传是调控植物叶片衰老的一种重要调控方式。该研究综述了植物叶片衰老过程中的表观遗传调控机制,包括组蛋白修饰、DNA甲基化、ATP依赖的染色质重塑和非编码RNA介导的调控,并对该领域今后的发展方向进行了展望。     

Novel markers of gene methylation and expression in breast cancer

An optimized methylation-sensitive restriction fingerprinting technique was used to search for differentially methylated CpG islands in the tumor genome and detected seven genes subject to abnormal epigenetic regulation in breast cancer: SEMA6B, BIN1, VCPIP1, LAMC3, KCNH2, CACNG4, and PSMF1. For each gene, the rate of promoter methylation and changes in expression were estimated in tumor and morphologically intact paired specimens of breast tissue (N = 100). Significant methylation rates of 38, 18, and 8% were found for SEMA6B, BIN1, and LAMC3, respectively. The genes were not methylated in morphologically intact breast tissue. The expression of SEMA6B, BIN1, VCPIP1, LAMC3, KCNH2, CACNG4, and PSMF1 was decreased in 44–94% of tumor specimens by the real-time RT-PCR assay. The most profound changes in SEMA6B and LAMC3 suggest that these genes can be included in biomarker panels for breast cancer diagnosis. Fine methylation mapping of the most frequently methylated CpG islands (SEMA6B, BIN1, and LAMC3) provides a fundamental basis for developing efficient methylation tests for these genes.     

Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma

Metastatic melanoma is a deadly treatment-resistant form of skin cancer whose global incidence is on the rise. During melanocyte transformation and melanoma progression the expression profile of many genes changes. Among these, a gene implicated in several steps of melanocyte development, TFAP2A, is frequently silenced; however, the molecular mechanism of TFAP2A silencing in human melanoma remains unknown. In this study, we measured TFAP2A mRNA expression in primary human melanocytes compared to 11 human melanoma samples by quantitative real-time RT-PCR. In addition, we assessed CpG DNA methylation of the TFAP2A promoter in these samples using bisulfite sequencing. Compared to primary melanocytes, which showed high TFAP2A mRNA expression and no promoter methylation, human melanoma samples showed decreased TFAP2A mRNA expression and increased promoter methylation. We further show that increased CpG methylation correlates with decreased TFAP2A mRNA expression. Using The Cancer Genome Atlas, we further identified TFAP2A as a gene displaying among the most decreased expression in stage 4 melanomas vs. non-stage 4 melanomas, and whose CpG methylation was frequently associated with lack of mRNA expression. Based on our data, we conclude that TFAP2A expression in human melanomas can be silenced by aberrant CpG methylation of the TFAP2A promoter. We have identified aberrant CpG DNA methylation as an epigenetic mark associated with TFAP2A silencing in human melanoma that could have significant implications for the therapy of human melanoma using epigenetic modifying drugs.     

Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma

Metastatic melanoma is a deadly treatment-resistant form of skin cancer whose global incidence is on the rise. During melanocyte transformation and melanoma progression the expression profile of many genes changes. Among these, a gene implicated in several steps of melanocyte development, TFAP2A, is frequently silenced; however, the molecular mechanism of TFAP2A silencing in human melanoma remains unknown. In this study, we measured TFAP2A mRNA expression in primary human melanocytes compared to 11 human melanoma samples by quantitative real-time RT-PCR. In addition, we assessed CpG DNA methylation of the TFAP2A promoter in these samples using bisulfite sequencing. Compared to primary melanocytes, which showed high TFAP2A mRNA expression and no promoter methylation, human melanoma samples showed decreased TFAP2A mRNA expression and increased promoter methylation. We further show that increased CpG methylation correlates with decreased TFAP2A mRNA expression. Using The Cancer Genome Atlas, we further identified TFAP2A as a gene displaying among the most decreased expression in stage 4 melanomas vs. non-stage 4 melanomas, and whose CpG methylation was frequently associated with lack of mRNA expression. Based on our data, we conclude that TFAP2A expression in human melanomas can be silenced by aberrant CpG methylation of the TFAP2A promoter. We have identified aberrant CpG DNA methylation as an epigenetic mark associated with TFAP2A silencing in human melanoma that could have significant implications for the therapy of human melanoma using epigenetic modifying drugs.     

PPARγ在脂肪生成中的遗传和表观遗传调控

过氧化物酶体增殖物激活受体γ(peroxisome proliferator-activated receptor gamma, PPARγ)是脂肪生成和脂肪组织发育的关键调控因子,另外在糖脂代谢、炎症和免疫反应等多种生物学过程中也发挥重要作用。近年来,对PPARγ基因的研究一直是脂肪生物学研究的热点。随着研究的不断深入,人们发现PPARγ基因不仅受遗传调控,还受DNA甲基化、组蛋白修饰、非编码RNA和染色质重塑等表观遗传调控。本文综述了PPARγ基因在脂肪生成中的遗传和表观遗传调控研究进展,探讨了未来PPARγ基因调控的研究方向和趋势。     

酿酒酵母INO80染色质重塑复合物调控基因表达的研究进展

表观遗传调控是真核生物基因表达精细调控的重要组成部分,主要包括DNA甲基化、组蛋白修饰和染色质重塑。其中,染色质重塑因子可影响组蛋白修饰酶和转录因子与特定位点的结合,在基因表达调控中占有重要地位。INO80复合物是进化上保守的染色质重塑复合物,能利用ATP水解获得的能量促进核小体的滑动和驱逐。INO80复合物除了在DNA复制、修复中发挥重要功能外,还通过改变DNA可及性调控酿酒酵母的基因表达。本文综述了染色质重塑复合物的分类及组成,重点介绍了酿酒酵母多亚基复合物INO80在基因表达调控中的重要功能,包括驱逐RNA聚合酶Ⅱ、响应信号转导途径和改变基因表达水平等,并着重总结了其在酿酒酵母环境胁迫响应机理中的研究进展。深入研究INO80染色质重塑复合物的功能,可为理解真核生物精细代谢调控的机制,并进一步开发基于染色质重塑等表观调控水平的微生物代谢工程和合成生物学改造策略,提高菌株的环境胁迫耐受性和发酵性能提供基础。     

Effect of β-1/3,1/6-glucan upon immune responses and bacteria in the gut of healthy common carp (Cyprinus carpio)

β-glucans are frequently included in the diet of healthy common carp Cyprinus carpio as a pre-emptive measure for combatting disease. In order to study the effect this has on the relationship between the gut bacteria and host immune response, carp were maintained on either a β-glucan free diet or feed containing 0.1% MacroGard®, a β-1/3, 1/6-glucan, for up to 7 weeks and analysis of innate immune gene expression and molecular analysis of the gut bacteria was performed. The data reveals feeding of MacroGard® to healthy carp does not induce bactericidal innate immune gene expression in the gut but does appear to alter bacterial species richness that did not have a negative effect on overall health. Analysis of innate immune gene expression within the upper midgut revealed that there were significant changes over time in the expression of Interleukin (il)-1β, inducible nitric oxide synthase (inos), mucin (muc2) and C-reactive protein (crp2). Diet did not affect the number of copies of the bacterial 16s rDNA gene in the gut, used as a as a measure of total bacteria population size. However, PCR-denaturing gradient gel electrophoresis (DGGE) analysis revealed a shift in bacterial species richness with MacroGard feeding. Bactericidal immune gene expression of crp2, muc2 and il-1β was weakly correlated with gut bacteria population size indicating a potentially limited role of these genes in interacting with the gut bacteria in healthy carp in order to maintain gut homeostatic conditions. These findings highlight the importance of considering both host immunity and the microbiome together in order to fully elucidate the effeect of immunomodulants, such as β-glucans, upon gut health.